Latest Aisling Capital Management LP Stock Portfolio
Aisling Capital Management LP Performance:
2024 Q4: 11.31%YTD: -21.82%2023: 117.62%
Performance for 2024 Q4 is 11.31%, and YTD is -21.82%, and 2023 is 117.62%.
About Aisling Capital Management LP and 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Aisling Capital Management LP reported an equity portfolio of $281.8 Millions as of 31 Dec, 2024.
The top stock holdings of Aisling Capital Management LP are BBIO, VRNA, SNDX. The fund has invested 59.1% of it's portfolio in BRIDGEBIO PHARMA INC. (BBIO) and 18.4% of portfolio in VERONA PHARMA PLC (VRNA).
The fund managers got completely rid off TECTONIC THERAPEUTIC INC (TECX) and RENEO PHARMACEUTICALS INC (RPHM) (RPHM) stocks. Aisling Capital Management LP opened new stock positions in ONKURE THERAPEUTICS, INC. (OKUR). The fund showed a lot of confidence in some stocks as they added substantially to MARKER THERAPEUTICS, INC. (MRKR) (MRKR).
The top stock holdings of Aisling Capital Management LP are BBIO, VRNA, SNDX. The fund has invested 59.1% of it's portfolio in BRIDGEBIO PHARMA INC. (BBIO) and 18.4% of portfolio in VERONA PHARMA PLC (VRNA).
The fund managers got completely rid off TECTONIC THERAPEUTIC INC (TECX) and RENEO PHARMACEUTICALS INC (RPHM) (RPHM) stocks. Aisling Capital Management LP opened new stock positions in ONKURE THERAPEUTICS, INC. (OKUR). The fund showed a lot of confidence in some stocks as they added substantially to MARKER THERAPEUTICS, INC. (MRKR) (MRKR).
Aisling Capital Management LP Annual Return Estimates Vs S&P 500
Our best estimate is that Aisling Capital Management LP made a return of 11.31% in the last quarter. In trailing 12 months, it's portfolio return was -21.82%.
New Buys
| Ticker | $ Bought |
|---|---|
| onkure therapeutics, inc. (okur) | 762,020 |
New stocks bought by Aisling Capital Management LP
Additions
| Ticker | % Inc. |
|---|---|
| marker therapeutics, inc. (mrkr) | 3.53 |
Additions to existing portfolio by Aisling Capital Management LP
Reductions
Sold off
| Ticker | $ Sold |
|---|---|
| reneo pharmaceuticals inc (rphm) | -1,506,330 |
| tectonic therapeutic inc (tecx) | -2,549,680 |
Aisling Capital Management LP got rid off the above stocks
Sector Distribution
Aisling Capital Management LP has about 95.6% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 95.6 |
| Others | 4.4 |
Market Cap. Distribution
Aisling Capital Management LP has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| MID-CAP | 77.5 |
| SMALL-CAP | 12.1 |
| MICRO-CAP | 5.7 |
| UNALLOCATED | 4.4 |
Stocks belong to which Index?
About 74.9% of the stocks held by Aisling Capital Management LP either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 74.9 |
| Others | 25.1 |
Aisling Capital Management LP Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Aisling Capital Management LP
Aisling Capital Management LP has 15 stocks in it's portfolio. About 98.4% of the portfolio is in top 10 stocks. SNDX proved to be the most loss making stock for the portfolio. VRNA was the most profitable stock for Aisling Capital Management LP last quarter.
Last Reported on: 12 Feb, 2025| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ACRS | aclaris therapeutics inc (acrs) | 0.38 | 434,455 | 1,077,450 | unchanged | 0.00 | ||
| BBIO | bridgebio pharma inc. (bbio) | 59.08 | 6,068,120 | 166,509,000 | unchanged | 0.00 | ||
| BMEA | biomea fusion inc (bmea) | 1.10 | 798,757 | 3,099,180 | unchanged | 0.00 | ||
| CMPS | compass pathways plc (cmps) | 1.29 | 964,500 | 3,645,810 | unchanged | 0.00 | ||
| ELEV | elevation oncology inc (elev) | 0.56 | 2,834,910 | 1,587,550 | unchanged | 0.00 | ||
| GLUE | monte rosa therapeutics inc (glue) | 3.63 | 1,472,330 | 10,218,000 | unchanged | 0.00 | ||
| MRKR | marker therapeutics, inc. (mrkr) | 0.36 | 325,370 | 1,011,900 | added | 3.53 | ||
| NUVB | nuvation bio inc. (nuvb) | 2.40 | 2,541,010 | 6,759,080 | unchanged | 0.00 | ||
| PSTX | poseida therapeutics inc. (pstx) | 3.55 | 1,043,270 | 10,015,400 | unchanged | 0.00 | ||
| RPHM | reneo pharmaceuticals inc (rphm) | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| SNDX | syndax pharmaceuticals, inc. (sndx) | 4.81 | 1,025,000 | 13,550,500 | unchanged | 0.00 | ||
| VIRX | viracta therapeutics inc (virx) | 0.02 | 288,571 | 46,171 | unchanged | 0.00 | ||
| VRNA | verona pharma plc (vrna) | 18.38 | 1,115,350 | 51,796,900 | unchanged | 0.00 | ||
| bicara therapeutics inc. (bcax) | 3.52 | 568,919 | 9,910,570 | unchanged | 0.00 | |||
| calcimedica, inc. (calc) | 0.66 | 521,114 | 1,844,740 | unchanged | 0.00 | |||
| onkure therapeutics, inc. (okur) | 0.27 | 88,607 | 762,020 | new | ||||
| tectonic therapeutic inc (tecx) | 0.00 | 0.00 | 0.00 | sold off | -100 | |||